Cargando…
Cleavage-Independent HIV-1 Trimers From CHO Cell Lines Elicit Robust Autologous Tier 2 Neutralizing Antibodies
Native flexibly linked (NFL) HIV-1 envelope glycoprotein (Env) trimers are cleavage-independent and display a native-like, well-folded conformation that preferentially displays broadly neutralizing determinants. The NFL platform simplifies large-scale production of Env by eliminating the need to co-...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976746/ https://www.ncbi.nlm.nih.gov/pubmed/29881382 http://dx.doi.org/10.3389/fimmu.2018.01116 |
_version_ | 1783327223462232064 |
---|---|
author | Bale, Shridhar Martiné, Alexandra Wilson, Richard Behrens, Anna-Janina Le Fourn, Valérie de Val, Natalia Sharma, Shailendra K. Tran, Karen Torres, Jonathan L. Girod, Pierre-Alain Ward, Andrew B. Crispin, Max Wyatt, Richard T. |
author_facet | Bale, Shridhar Martiné, Alexandra Wilson, Richard Behrens, Anna-Janina Le Fourn, Valérie de Val, Natalia Sharma, Shailendra K. Tran, Karen Torres, Jonathan L. Girod, Pierre-Alain Ward, Andrew B. Crispin, Max Wyatt, Richard T. |
author_sort | Bale, Shridhar |
collection | PubMed |
description | Native flexibly linked (NFL) HIV-1 envelope glycoprotein (Env) trimers are cleavage-independent and display a native-like, well-folded conformation that preferentially displays broadly neutralizing determinants. The NFL platform simplifies large-scale production of Env by eliminating the need to co-transfect the precursor-cleaving protease, furin that is required by the cleavage-dependent SOSIP trimers. Here, we report the development of a CHO-M cell line that expressed BG505 NFL trimers at a high level of homogeneity and yields of ~1.8 g/l. BG505 NFL trimers purified by single-step lectin-affinity chromatography displayed a native-like closed structure, efficient recognition by trimer-preferring bNAbs, no recognition by non-neutralizing CD4 binding site-directed and V3-directed antibodies, long-term stability, and proper N-glycan processing. Following negative-selection, formulation in ISCOMATRIX adjuvant and inoculation into rabbits, the trimers rapidly elicited potent autologous tier 2 neutralizing antibodies. These antibodies targeted the N-glycan “hole” naturally present on the BG505 Env proximal to residues at positions 230, 241, and 289. The BG505 NFL trimers that did not expose V3 in vitro, elicited low-to-no tier 1 virus neutralization in vivo, indicating that they remained intact during the immunization process, not exposing V3. In addition, BG505 NFL and BG505 SOSIP trimers expressed from 293F cells, when formulated in Adjuplex adjuvant, elicited equivalent BG505 tier 2 autologous neutralizing titers. These titers were lower in potency when compared to the titers elicited by CHO-M cell derived trimers. In addition, increased neutralization of tier 1 viruses was detected. Taken together, these data indicate that both adjuvant and cell-type expression can affect the elicitation of tier 2 and tier 1 neutralizing responses in vivo. |
format | Online Article Text |
id | pubmed-5976746 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-59767462018-06-07 Cleavage-Independent HIV-1 Trimers From CHO Cell Lines Elicit Robust Autologous Tier 2 Neutralizing Antibodies Bale, Shridhar Martiné, Alexandra Wilson, Richard Behrens, Anna-Janina Le Fourn, Valérie de Val, Natalia Sharma, Shailendra K. Tran, Karen Torres, Jonathan L. Girod, Pierre-Alain Ward, Andrew B. Crispin, Max Wyatt, Richard T. Front Immunol Immunology Native flexibly linked (NFL) HIV-1 envelope glycoprotein (Env) trimers are cleavage-independent and display a native-like, well-folded conformation that preferentially displays broadly neutralizing determinants. The NFL platform simplifies large-scale production of Env by eliminating the need to co-transfect the precursor-cleaving protease, furin that is required by the cleavage-dependent SOSIP trimers. Here, we report the development of a CHO-M cell line that expressed BG505 NFL trimers at a high level of homogeneity and yields of ~1.8 g/l. BG505 NFL trimers purified by single-step lectin-affinity chromatography displayed a native-like closed structure, efficient recognition by trimer-preferring bNAbs, no recognition by non-neutralizing CD4 binding site-directed and V3-directed antibodies, long-term stability, and proper N-glycan processing. Following negative-selection, formulation in ISCOMATRIX adjuvant and inoculation into rabbits, the trimers rapidly elicited potent autologous tier 2 neutralizing antibodies. These antibodies targeted the N-glycan “hole” naturally present on the BG505 Env proximal to residues at positions 230, 241, and 289. The BG505 NFL trimers that did not expose V3 in vitro, elicited low-to-no tier 1 virus neutralization in vivo, indicating that they remained intact during the immunization process, not exposing V3. In addition, BG505 NFL and BG505 SOSIP trimers expressed from 293F cells, when formulated in Adjuplex adjuvant, elicited equivalent BG505 tier 2 autologous neutralizing titers. These titers were lower in potency when compared to the titers elicited by CHO-M cell derived trimers. In addition, increased neutralization of tier 1 viruses was detected. Taken together, these data indicate that both adjuvant and cell-type expression can affect the elicitation of tier 2 and tier 1 neutralizing responses in vivo. Frontiers Media S.A. 2018-05-24 /pmc/articles/PMC5976746/ /pubmed/29881382 http://dx.doi.org/10.3389/fimmu.2018.01116 Text en Copyright © 2018 Bale, Martiné, Wilson, Behrens, Le Fourn, de Val, Sharma, Tran, Torres, Girod, Ward, Crispin and Wyatt. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Bale, Shridhar Martiné, Alexandra Wilson, Richard Behrens, Anna-Janina Le Fourn, Valérie de Val, Natalia Sharma, Shailendra K. Tran, Karen Torres, Jonathan L. Girod, Pierre-Alain Ward, Andrew B. Crispin, Max Wyatt, Richard T. Cleavage-Independent HIV-1 Trimers From CHO Cell Lines Elicit Robust Autologous Tier 2 Neutralizing Antibodies |
title | Cleavage-Independent HIV-1 Trimers From CHO Cell Lines Elicit Robust Autologous Tier 2 Neutralizing Antibodies |
title_full | Cleavage-Independent HIV-1 Trimers From CHO Cell Lines Elicit Robust Autologous Tier 2 Neutralizing Antibodies |
title_fullStr | Cleavage-Independent HIV-1 Trimers From CHO Cell Lines Elicit Robust Autologous Tier 2 Neutralizing Antibodies |
title_full_unstemmed | Cleavage-Independent HIV-1 Trimers From CHO Cell Lines Elicit Robust Autologous Tier 2 Neutralizing Antibodies |
title_short | Cleavage-Independent HIV-1 Trimers From CHO Cell Lines Elicit Robust Autologous Tier 2 Neutralizing Antibodies |
title_sort | cleavage-independent hiv-1 trimers from cho cell lines elicit robust autologous tier 2 neutralizing antibodies |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976746/ https://www.ncbi.nlm.nih.gov/pubmed/29881382 http://dx.doi.org/10.3389/fimmu.2018.01116 |
work_keys_str_mv | AT baleshridhar cleavageindependenthiv1trimersfromchocelllineselicitrobustautologoustier2neutralizingantibodies AT martinealexandra cleavageindependenthiv1trimersfromchocelllineselicitrobustautologoustier2neutralizingantibodies AT wilsonrichard cleavageindependenthiv1trimersfromchocelllineselicitrobustautologoustier2neutralizingantibodies AT behrensannajanina cleavageindependenthiv1trimersfromchocelllineselicitrobustautologoustier2neutralizingantibodies AT lefournvalerie cleavageindependenthiv1trimersfromchocelllineselicitrobustautologoustier2neutralizingantibodies AT devalnatalia cleavageindependenthiv1trimersfromchocelllineselicitrobustautologoustier2neutralizingantibodies AT sharmashailendrak cleavageindependenthiv1trimersfromchocelllineselicitrobustautologoustier2neutralizingantibodies AT trankaren cleavageindependenthiv1trimersfromchocelllineselicitrobustautologoustier2neutralizingantibodies AT torresjonathanl cleavageindependenthiv1trimersfromchocelllineselicitrobustautologoustier2neutralizingantibodies AT girodpierrealain cleavageindependenthiv1trimersfromchocelllineselicitrobustautologoustier2neutralizingantibodies AT wardandrewb cleavageindependenthiv1trimersfromchocelllineselicitrobustautologoustier2neutralizingantibodies AT crispinmax cleavageindependenthiv1trimersfromchocelllineselicitrobustautologoustier2neutralizingantibodies AT wyattrichardt cleavageindependenthiv1trimersfromchocelllineselicitrobustautologoustier2neutralizingantibodies |